≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Benign neoplasm: Liver/bile ducts

DOID EFO Endpoint Browser PheWeb

CD2_BENIGN_LIVE_BILE

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

None

0 out of 7 registries used, show all original rules.

0

4. Check minimum number of events

None

0

5. Include endpoints

882

6. Filter based on genotype QC (FinnGen only)

882

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2

Similar endpoints

↥

List of similar endpoints to Benign neoplasm: Liver/bile ducts based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Similar with more cases:

Venn diagram with a set fully inside an highlighted set Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 4652 3169 1446
Only index persons 4204 2945 1259
Unadjusted period prevalence (%)
Whole population 0.07 0.09 0.04
Only index persons 0.09 0.11 0.05
Median age at first event (years)
Whole population 53.05 49.88 59.76
Only index persons 51.67 48.81 58.37

-FinnGen-

Key figures

All Female Male
Number of individuals 882 627 255
Unadjusted period prevalence (%) 0.18 0.21 0.11
Median age at first event (years) 53.11 49.51 61.98

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
765
Matched controls
7651
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D13.4
ICD-10 Finland
Benign neoplasm: Liver
+∞
323.0
666
*
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
65.9
151.7
174
34
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
27.1
105.7
148
67
D13.5
ICD-10 Finland
Benign neoplasm: Extrahepatic bile ducts
+∞
90.4
85
*
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
20.4
65.8
100
56
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
6.0
53.3
161
324
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
16.6
49.8
81
54
R93.2
ICD-10 Finland
Abnormal findings on diagnostic imaging of liver and biliary tract
30.9
31.0
41
14
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.5
30.0
355
1983
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
6.5
24.8
66
109
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.7
23.2
184
801
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.3
21.7
263
1425
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
8.2
20.1
45
58
K76.89
ICD-10 Finland
Other specified diseases of liver
107.9
19.7
21
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.0
18.5
114
419
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.7
17.8
134
559
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
13.0
17.2
30
24
UJF32
NOMESCO Finland
Coloscopy
2.1
16.3
218
1206
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
2.6
15.3
120
509
JN1CD
NOMESCO Finland
Very extensive CT examination of upper part of abdomen
16.9
14.8
23
14
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
18.8
14.8
22
12
D18.0
ICD-10 Finland
Haemangioma, any site
5.7
14.1
40
73
A02BC02
ATC
pantoprazole; systemic
1.8
13.9
489
3777
J01MA02
ATC
ciprofloxacin; systemic
1.8
11.9
290
1956
K76.80
ICD-10 Finland
Hepatic cyst
14.9
11.8
19
13
8170/3-C22.0
ICD-O-3
Hepatocellular carcinoma, NOS, of liver
30.5
11.7
15
5
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.9
11.5
195
1162
21150
ICD-8 Finland
Benign neoplasm of other parts of digestive system, Hepatis
+∞
11.5
11
*
JJB71
NOMESCO Finland
Laparoscopic resection of liver
121.8
11.5
12
*
JJ3AT
NOMESCO Finland
Cytology of liver with ultrasound guidance
44.0
10.9
13
*
JJ1CE
NOMESCO Finland
Liver, bile duct and pancreas endoscopic ultrasound examination
28.5
10.8
14
5
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
2.3
10.7
107
512
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
21.8
10.7
15
7
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
12.3
10.4
18
15
JJA21
NOMESCO Finland
Laparoscopic biopsy of liver
40.6
10.0
12
*
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.2
9.8
105
520
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
17.8
9.4
14
8
TPH04
NOMESCO Finland
Cathetrisation of vein
1.9
9.4
151
878
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
13.9
9.2
15
11
N02AX02
ATC
tramadol; systemic, rectal
1.6
9.1
306
2225
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
8.9
203
1320
D13.9
ICD-10 Finland
Benign neoplasm: Ill-defined sites within the digestive system
50.6
8.7
10
*
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
8.6
163
999
A02BC03
ATC
lansoprazole; oral
1.7
8.4
216
1450
130
Kela drug reimbursment
Malignant tumour
2.5
8.2
62
256
A06AC01
ATC
ispaghula (psylla seeds); oral
1.7
8.2
180
1152
A02BC05
ATC
esomeprazole; systemic
1.6
8.1
299
2203
UJK02
NOMESCO Finland
ERCP
4.5
8.0
27
62
N02BE01
ATC
paracetamol; systemic, rectal
1.7
7.9
640
5713
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
4.7
7.7
25
55
K76.9
ICD-10 Finland
Liver disease, unspecified
6.0
7.7
20
34
K30
ICD-10 Finland
Functional dyspepsia
2.1
7.7
86
433
R51.80
ICD-10 Finland
Headache
1.9
7.6
120
686
D13.2
ICD-10 Finland
Benign neoplasm: Duodenum
25.3
7.6
10
*
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
9.5
7.3
14
15
XJA00
NOMESCO Finland
Intraoperative abdominal ultrasonography
+∞
7.3
7
*
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
6.1
7.1
18
30
C22.9
ICD-10 Finland
Malignant neoplasm: Liver, unspecified
12.2
7.1
12
10
JN4CD
NOMESCO Finland
Very extensive body CT
3.2
7.0
34
108
P01AB01
ATC
metronidazole; oral, rectal
1.5
7.0
301
2283
R06.0
ICD-10 Finland
Dyspnoea
1.7
6.9
170
1120
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
3.8
6.8
27
73
A02BC01
ATC
omeprazole; systemic
1.6
6.8
201
1392
JJB30
NOMESCO Finland
Excision of two segments of liver
40.4
6.8
8
*
K83.9
ICD-10 Finland
Disease of biliary tract, unspecified
16.9
6.8
10
6
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.8
6.7
126
767
WX402
NOMESCO Finland
General anaesthesia
1.8
6.7
124
750
C22.1
ICD-10 Finland
Malignant neoplasm: Intrahepatic bile duct carcinoma
22.7
6.7
9
*
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
3.0
6.7
38
133
K83.0
ICD-10 Finland
Cholangitis
6.0
6.6
17
29
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
3.7
6.6
27
75
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
4.9
6.6
20
42
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.1
6.6
76
387
WX302
NOMESCO Finland
Thoracal epidural anesthesy
2.6
6.5
45
179
K83.1
ICD-10 Finland
Obstruction of bile duct
6.6
6.4
15
23
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.3
6.4
56
252
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.8
6.3
113
677
B01AB05
ATC
enoxaparin; parenteral
1.6
6.3
208
1476
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.5
6.3
45
184
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.6
6.3
44
176
JJA20
NOMESCO Finland
Open biopsy of liver
18.2
6.3
9
5
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.9
6.2
91
509
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
2.2
6.1
62
297
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
2.4
6.1
52
230
Z3231
NOMESCO Finland
Registered nurse
1.6
6.1
187
1303

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
152
83
21.92
195.63
1.8
2.1
u/ml
3.5
52.8
0.51
152
77
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
281
646
5.92
122.14
2.5
4.0
ug/l
2.6
25.5
1.15
195
523
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
168
233
8.67
118.84
2.1
3.2
u/ml
21.4
1251.0
0.98
147
200
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
650
3669
3.93
73.70
6.9
5.7
umol/l
10.5
10.6
0.15
625
3477
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
249
777
4.07
70.35
4.0
2.3
umol/l
5.2
7.0
2.11
221
672
(40768441) Liver Pathology biopsy report
66
53
13.38
68.18
1.3
1.2
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
90
125
7.90
62.48
2.1
3.8
u/ml
134.5
2357.1
0.60
83
118
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
206
640
3.89
57.57
2.4
2.1
g/l
0.2
0.2
1.49
199
603
(3024561) Albumin [Mass/volume] in Serum or Plasma
514
2863
2.91
52.18
5.8
4.4
g/l
36.0
36.1
0.15
487
2672
(3032080) INR in Blood by Coagulation assay
465
2558
2.73
46.69
7.0
7.7
inr
1.1
1.2
0.16
99
791
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
766
5514
3.96
46.17
9.5
7.0
u/l
80.5
76.5
1.91
737
5187
(3033658) Prothrombin time (PT) actual/Normal
344
1746
2.59
38.98
5.9
3.4
%
96.6
93.9
1.15
336
1685
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
402
2247
2.45
36.43
3.2
2.4
u/l
57.3
55.9
0.24
371
2083
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
423
2441
2.41
35.42
4.2
3.1
u/l
31.3
30.3
0.36
408
2327
(3007566) Smooth muscle Ab [Titer] in Serum
80
185
4.66
32.48
1.3
1.1
titre
52.2
88.6
—
9
14
(3034770) Mitochondria Ab [Titer] in Serum
78
195
4.29
28.64
1.3
1.2
—
846.7
—
0
6
(3013826) Glucose [Moles/volume] in Serum or Plasma
569
4029
2.16
25.73
6.4
4.4
mmol/l
6.6
6.5
0.18
546
3732
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
498
3419
2.05
23.61
4.0
3.9
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
296
1696
2.12
22.83
2.4
2.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
650
5047
2.09
20.42
4.3
2.9
u/l
63.3
43.3
6.82
625
4766
(3020779) Urea [Moles/volume] in Serum or Plasma
123
503
2.68
20.38
8.7
7.1
mmol/l
8.2
8.9
0.46
117
479
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
141
623
2.50
19.91
3.4
2.3
u/l
31.2
35.9
0.69
117
530
(3044640) Blood type and Crossmatch panel - Blood
354
2261
1.94
19.50
2.6
2.1
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
188
961
2.22
18.95
3.1
2.2
g/l
2.5
2.4
0.80
176
889
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
177
883
2.26
18.93
3.2
2.2
%
23.8
23.1
0.28
163
757
(3022948) Iron [Moles/volume] in Serum or Plasma
199
1047
2.16
18.63
3.1
2.2
umol/l
13.9
13.6
0.32
189
965
(3013650) Neutrophils [#/volume] in Blood by Automated count
559
4201
1.90
18.19
8.7
8.8
e9/l
4.5
4.0
3.91
486
3707
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
19
17
11.40
18.04
1.3
4.2
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
669
5367
2.02
17.57
4.3
3.9
mm/h
11.8
11.1
0.64
628
4994
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
467
3345
1.84
17.38
8.9
6.1
mmol/l
1.2
1.2
0.09
417
2810
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
830
7346
3.20
16.22
17.0
12.4
mg/l
24.0
21.6
1.13
715
5754
(3019198) Lymphocytes [#/volume] in Blood
500
3728
1.79
15.62
6.1
5.6
e9/l
2.4
1.9
0.55
435
3337
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
423
3007
1.78
15.53
8.3
5.5
mmol/l
1.2
1.2
0.04
391
2729
(3001604) Monocytes [#/volume] in Blood
487
3619
1.77
15.24
6.1
5.6
e9/l
0.6
0.6
0.56
415
3177
(3013115) Eosinophils [#/volume] in Blood
501
3760
1.77
15.08
6.3
5.9
e9/l
0.2
0.2
0.04
430
3347
(3006315) Basophils [#/volume] in Blood
488
3635
1.77
15.08
6.1
5.6
e9/l
0.0
0.0
0.71
417
3192
(3019550) Sodium [Moles/volume] in Serum or Plasma
829
7415
2.96
14.25
18.9
13.8
mmol/l
139.6
139.6
0.04
820
7217
(3023103) Potassium [Moles/volume] in Serum or Plasma
829
7431
2.92
13.88
18.9
13.9
mmol/l
3.9
4.0
1.54
819
7220
(3014576) Chloride [Moles/volume] in Serum or Plasma
147
767
2.10
13.75
11.1
6.7
mmol/l
105.2
104.3
2.24
147
752
(3003458) Phosphate [Moles/volume] in Serum or Plasma
153
819
2.05
13.34
6.8
5.1
mmol/l
1.0
1.0
0.43
140
755
(3007164) IgA [Mass/volume] in Serum or Plasma
244
1531
1.82
13.20
1.5
1.4
g/l
2.1
2.3
1.01
168
951
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
106
493
2.31
13.16
4.1
3.6
ng/l
84.2
80.9
0.15
88
445
(3031040) Bacteria [#/volume] in Urine by Automated count
591
4768
1.73
12.66
5.0
4.2
e6/l
410.6
1764.0
—
7
66
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
167
940
1.96
12.59
1.9
1.7
%
1.4
1.4
0.43
151
842
(40768797) Stomach Pathology biopsy report
175
1007
1.92
12.34
1.3
1.2
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
334
2341
1.69
12.02
6.3
5.7
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
459
3507
1.64
11.71
6.4
5.7
%
28.3
28.5
0.14
433
3288
(3037522) Nuclear Ab [Titer] in Serum
177
1040
1.88
11.66
1.5
1.3
titre
591.0
525.9
0.17
40
230
(4035726)
114
575
2.13
11.57
1.4
1.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
611
5031
1.70
11.55
4.7
4.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
167
966
1.90
11.54
2.1
2.3
ug/g
125.7
111.5
0.24
126
763
(3018010) Neutrophils/100 leukocytes in Blood
454
3473
1.63
11.42
6.3
5.5
%
58.1
57.0
1.39
429
3265
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
265
1766
1.72
11.38
1.3
1.2
u/ml
0.6
1.6
2.43
78
494
(36304419) Bacteria [Presence] in Urine
270
1815
1.70
11.21
3.6
2.8
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
446
3410
1.62
11.14
6.6
5.9
%
8.0
8.3
2.41
421
3210
(3006504) Eosinophils/100 leukocytes in Blood
444
3393
1.62
11.10
6.4
5.6
%
2.7
2.8
0.64
419
3172
(3018095) Leukocytes [#/volume] in Urine
340
2435
1.64
11.03
4.7
3.5
e6/l
39.8
92.8
1.74
231
1661
(3022096) Basophils/100 leukocytes in Blood
431
3273
1.62
11.03
6.4
5.7
%
0.6
0.7
0.36
405
3063
(3017143) Hepatitis C virus Ab [Presence] in Serum
157
916
1.87
10.50
1.5
1.6
—
—
—
0
0
(3036489) Thrombin time
65
269
2.53
10.42
2.8
1.9
s
23.2
21.2
0.48
57
238
(40768804) Tissue Pathology biopsy report
401
3025
1.60
10.33
2.6
2.0
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
289
2014
1.65
10.29
4.1
3.0
e6/l
53.0
101.4
0.58
210
1535
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
170
1025
1.82
10.21
3.5
2.8
e6/l
2.8
3.0
0.09
90
543
(3030467) Casts [#/volume] in Urine by Automated count
269
1846
1.66
10.15
3.8
2.9
e6/l
0.3
0.4
0.37
186
1368
(3022145) Colonoscopy Study observation
140
796
1.90
10.12
1.4
1.3
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
178
1095
1.78
9.98
2.9
2.6
e6/l
1.4
1.1
0.25
95
610
(3023368) Bacteria identified in Blood by Culture
250
1693
1.67
9.89
4.1
4.0
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
254
1739
1.65
9.59
2.5
2.0
mg/l
2.8
2.9
0.41
216
1489
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
248
1688
1.65
9.58
2.1
1.7
mg/l
1.0
1.0
0.05
195
1271
(3003396) Base excess in Arterial blood by calculation
124
693
1.92
9.42
10.0
7.7
mmol/l
0.4
1.2
1.54
105
548
(3002256) Pathology report gross observation
153
915
1.81
9.39
1.3
1.3
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
71
323
2.30
9.26
7.9
10.1
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
119
660
1.93
9.24
4.0
4.3
u/l
224.4
240.5
1.03
113
626
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
100
534
1.98
8.66
3.0
2.4
ml/min/173m2
77.5
70.6
0.78
42
212
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
187
1220
1.68
8.38
3.4
3.4
ng/l
1806.7
300.0
0.62
128
865
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
34
113
3.09
8.23
1.4
1.3
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
252
1788
1.57
7.98
2.9
2.4
umol/l
1325.8
5631.8
2.45
223
1546
(3000991) Gas panel - Venous blood
87
464
1.97
7.56
12.7
8.8
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
21
54
3.96
7.46
1.5
1.1
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
330
2529
1.49
7.15
3.3
3.3
ng/l
27.8
31.4
0.23
199
1588
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
383
3030
1.47
7.04
2.9
2.2
nmol/l
72.7
76.1
1.71
348
2746
(3012095) Magnesium [Moles/volume] in Serum or Plasma
164
1079
1.64
7.02
4.0
3.1
mmol/l
0.8
0.8
0.13
149
1010
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
24
71
3.45
7.01
1.4
1.2
u/l
38.8
52.3
1.60
16
50
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
833
7814
2.19
6.85
13.7
9.6
u/l
29.3
25.5
6.38
816
7561
(3015377) Calcium [Moles/volume] in Serum or Plasma
306
2327
1.48
6.82
3.0
3.3
mmol/l
2.4
2.3
0.89
266
2053
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
349
2736
1.46
6.61
2.1
1.9
pmol/l
99.5
96.5
0.53
200
1442
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
132
835
1.68
6.56
8.2
6.3
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
424
3452
1.44
6.54
3.9
2.7
ug/l
115.7
102.6
0.68
403
3222
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
28
96
2.98
6.47
1.0
1.0
u/ml
0.1
0.1
—
9
21
(3042936) Bacteria identified in Isolate by Culture
149
977
1.63
6.44
2.2
1.9
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
29
102
2.91
6.42
1.0
1.1
u/ml
5.6
6.8
0.12
13
35
(3011397) Hemoglobin [Presence] in Urine by Test strip
224
1620
1.51
6.31
3.7
3.4
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
120
749
1.70
6.26
26.1
20.2
inr
1.3
1.2
0.08
12
104
(40758558) Short blood count panel - Blood
244
1801
1.49
6.21
7.3
6.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
98
581
1.77
6.13
1.4
1.2
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
35
140
2.56
6.09
1.0
1.1
u/ml
1.5
5.4
1.50
19
66
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
81
454
1.86
6.08
1.5
1.7
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
47
216
2.24
6.05
1.5
1.4
ug/g
303.6
295.1
0.09
25
124
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
37
153
2.48
6.02
1.1
1.1
u/ml
0.7
1.5
0.76
13
56
(3018418) pH of Serum or Plasma
264
1990
1.47
6.02
5.6
3.8
ph
7.4
7.4
0.63
36
382
(4010399)
85
486
1.83
6.00
1.6
1.4
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
436
3610
1.41
5.90
4.1
3.4
estimate
0.0
0.0
0.00
61
696
(3009261) Glucose [Presence] in Urine by Test strip
441
3661
1.41
5.87
4.0
3.4
estimate
0.0
0.0
0.50
62
681
(3021601) Nitrite [Presence] in Urine by Test strip
436
3613
1.41
5.86
5.6
4.6
estimate
0.0
0.0
0.50
65
700
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
214
1557
1.49
5.80
1.7
1.6
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
53
261
2.10
5.76
1.7
1.7
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
48
228
2.17
5.71
1.4
1.3
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
61
318
1.99
5.69
1.9
2.1
u/l
42.2
39.6
0.53
56
288
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
63
333
1.96
5.65
2.7
2.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
39
171
2.34
5.61
4.2
2.8
u/ml
0.3
0.4
1.59
17
85
(3008401) Mugwort IgE Ab [Units/volume] in Serum
33
135
2.50
5.51
1.0
1.1
u/ml
0.3
0.9
1.59
12
54
(40761511) CBC panel - Blood by Automated count
821
7746
1.87
5.33
16.2
11.8
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
40
182
2.25
5.30
2.4
2.9
—
—
—
0
0
(3026782) Osmolality of Urine
183
1317
1.49
5.18
3.9
2.6
mosm/kgh2o
542.8
550.8
0.18
150
1129
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
13
31
4.24
5.10
2.2
2.1
nmol/l
2.2
8.6
—
8
22
(3013139) Helicobacter pylori Ag [Presence] in Stool
84
503
1.74
5.09
1.2
1.2
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
168
1195
1.50
5.03
2.9
2.7
mmol/l
2.5
2.4
1.46
151
1057
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
652
5867
1.43
5.02
4.7
4.1
pmol/l
14.6
14.6
0.09
604
5396
(3026008) Bacteria identified in Urine by Culture
268
2087
1.41
4.96
2.7
2.8
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
56
298
1.94
4.95
1.6
1.6
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
31
130
2.44
4.94
1.0
1.0
u/ml
0.4
2.2
1.12
12
29
(3044889) 12 lead EKG panel
562
4938
1.38
4.93
3.8
3.5
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
748
6919
1.53
4.93
15.3
11.2
ml/min/173m2
86.3
84.8
1.09
633
5646
(3000850) Epithelial cells [#/volume] in Urine
192
1411
1.46
4.87
3.2
2.4
e6/l
5.3
7.0
0.83
160
1237
(3014133) Dog dander IgE Ab [Units/volume] in Serum
28
113
2.53
4.83
1.0
1.0
u/ml
1.4
3.2
0.92
14
36
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
19
62
3.11
4.81
1.2
1.0
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
73
428
1.77
4.77
1.1
1.0
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
120
803
1.57
4.74
1.8
1.6
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
84
515
1.70
4.69
1.2
1.3
u/ml
115.5
206.0
1.06
77
476
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
32
140
2.33
4.66
1.2
1.3
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
742
6885
1.49
4.47
5.7
4.8
mu/l
1.7
2.0
1.02
697
6372
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
253
1994
1.38
4.27
2.1
2.1
u/l
152.8
212.6
0.73
239
1883
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
81
508
1.65
4.17
2.0
2.3
ug/l
7.2
6.3
0.14
72
445
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
36
174
2.11
4.17
2.5
4.0
mg/l
38.3
33.2
0.18
31
140
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
28
124
2.30
4.00
3.4
2.1
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
221
1722
1.38
3.96
2.7
3.0
ng/l
1438.3
1072.7
0.52
189
1444
(3034860) Kappa light chains.free [Mass/volume] in Serum
35
174
2.05
3.79
2.6
4.0
mg/l
45.0
88.4
0.60
30
140
(4306422)
26
115
2.30
3.74
1.3
1.2
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
100
679
1.53
3.71
2.1
2.5
%
1.9
1.8
0.16
89
600
(3009508) Creatinine [Moles/volume] in Urine
251
2014
1.34
3.70
3.7
3.1
mmol/l
7.9
7.6
0.53
223
1699
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
14
45
3.15
3.66
2.1
1.5
u/l
4.4
8.9
—
9
21
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
19
73
2.64
3.66
1.3
1.7
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
16
56
2.89
3.64
2.4
2.9
—
—
—
0
0
(3020891) Body temperature
43
235
1.87
3.58
10.3
4.7
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
58
348
1.71
3.55
1.5
1.7
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
63
387
1.68
3.54
1.4
1.5
—
—
—
0
0
(4268621)
21
87
2.45
3.49
2.8
2.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
173
1321
1.39
3.48
1.7
1.6
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
16
58
2.79
3.43
1.6
1.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
101
700
1.50
3.42
1.6
1.8
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
102
710
1.49
3.38
1.7
1.8
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
35
182
1.96
3.38
1.2
1.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
178
1372
1.37
3.38
1.3
1.3
iu/ml
26.9
32.1
0.25
48
436
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
28
134
2.13
3.37
1.5
1.2
u/ml
1.9
5.9
1.10
13
47
(3019309) Folate [Moles/volume] in Red Blood Cells
154
1163
1.39
3.30
1.7
1.7
nmol/l
1079.6
1213.0
1.13
121
882
(3043409) Potassium [Moles/volume] in Arterial blood
36
191
1.92
3.29
10.9
4.0
mmol/l
3.8
3.8
0.33
36
177
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
26
122
2.17
3.28
1.2
1.1
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
45
257
1.79
3.28
1.9
2.2
g/l
1.5
1.5
0.09
38
222
(3020682) Albumin/Creatinine [Ratio] in Urine
240
1944
1.32
3.27
4.6
4.0
mg/mmol
15.1
8.9
0.65
171
1213
(3006922) Hepatitis E virus Ab [Presence] in Serum
13
43
3.05
3.26
1.2
1.0
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
372
3196
1.28
3.25
9.6
8.7
e9/l
0.0
0.0
0.22
293
2641
(3017732) Neutrophils [#/volume] in Blood
77
509
1.56
3.24
2.1
2.6
e9/l
4.4
4.1
0.45
53
411
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
77
509
1.56
3.24
3.2
3.4
pmol/l
4.5
4.6
0.25
69
448
(3012544) pH of Venous blood
82
550
1.54
3.24
4.9
3.5
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
24
110
2.21
3.21
1.2
1.0
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
26
124
2.13
3.16
1.5
1.2
u/ml
1.3
3.7
—
9
38
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
92
636
1.50
3.16
1.8
1.8
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
170
1314
1.36
3.16
1.3
1.3
u/ml
16.7
12.1
0.27
77
516
(3020961) Endomysium IgA Ab [Titer] in Serum
64
408
1.61
3.14
1.1
1.1
—
167.3
—
0
7
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
118
860
1.43
3.10
1.3
1.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
67
434
1.59
3.08
1.3
1.2
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
99
700
1.47
3.05
2.0
2.0
nmol/l
397.5
376.0
0.41
84
651
(3009445) Proteinase 3 Ab [Units/volume] in Serum
48
286
1.72
3.04
1.3
1.4
—
4.4
—
0
6
(3018405) Lactate [Moles/volume] in Arterial blood
40
226
1.81
3.03
10.1
4.1
mmol/l
1.1
1.3
1.26
40
220
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
13
45
2.92
3.03
5.8
7.3
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
671
6238
1.32
3.03
21.4
15.2
%
13.7
13.6
0.53
665
6120
(3019060) Gas panel - Arterial blood
62
396
1.61
3.03
7.5
5.1
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
9
21
4.32
3.00
1.0
1.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
228
1855
1.31
2.98
3.8
3.3
mg/l
811.7
405.2
0.44
159
1173
(3016650) Hepatitis A virus Ab [Presence] in Serum
24
114
2.14
2.96
1.1
1.1
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
200
1601
1.32
2.94
1.6
1.5
nmol/l
18.8
20.8
1.40
172
1380
(40761535) Cells panel - Urine sediment
79
539
1.51
2.90
3.6
3.3
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
9
22
4.12
2.88
3.4
2.3
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
78
532
1.51
2.87
5.1
3.5
mmol/l
2.0
1.9
0.03
65
420
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
12
41
2.95
2.86
1.2
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
12
41
2.95
2.86
1.2
1.0
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
43
254
1.73
2.83
1.7
1.5
g/l
1.3
1.2
0.73
43
241
(3023520) Reticulocytes [#/volume] in Blood
73
493
1.52
2.82
2.4
2.6
e9/l
67.0
71.4
0.72
57
378
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
16
65
2.49
2.80
1.4
1.8
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
8
18
4.47
2.80
1.0
1.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
38
635
0.58
2.79
5.4
3.5
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
9
23
3.94
2.78
1.1
1.1
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
26
131
2.01
2.78
9.6
6.1
iu/ml
29837.2
207.8
—
5
19
(3042733) HLA Ab [Presence] in Serum
7
14
5.03
2.73
2.9
5.3
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
847
8229
1.74
2.68
26.5
18.5
e9/l
266.3
256.9
3.29
829
8040
(3024731) MCV [Entitic volume]
847
8232
1.73
2.63
26.5
18.4
fl
90.3
90.8
2.17
839
8128
(3038177) Helicobacter pylori Ab [Presence] in Serum
26
134
1.97
2.62
1.0
1.1
—
—
—
0
0
(3035941) MCH [Entitic mass]
847
8234
1.72
2.60
26.5
18.4
pg
30.0
30.2
3.59
839
8129
(3048929) Epstein Barr virus Ab [Presence] in Serum
42
253
1.69
2.60
1.3
1.2
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
847
8235
1.72
2.59
26.6
18.5
e12/l
4.5
4.5
0.16
831
8029
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
8
20
4.03
2.57
1.0
1.1
%
88.1
100.8
—
8
20
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
8
20
4.03
2.57
1.0
1.1
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
847
8237
1.71
2.56
26.6
18.5
e9/l
7.1
6.7
6.92
831
8023
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
703
6624
1.30
2.56
6.5
5.2
mmol/mol
39.8
39.1
1.20
665
6189
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
5
7
7.18
2.55
8.4
3.1
mmol/l
5.8
8.0
—
5
7
(3000963) Hemoglobin [Mass/volume] in Blood
847
8240
1.70
2.51
26.7
18.6
g/l
134.2
134.9
0.88
840
8132
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
134
1035
1.35
2.50
1.7
1.8
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
736
6985
1.32
2.49
4.3
3.7
mmol/l
1.4
1.3
5.86
687
6465
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
13
51
2.57
2.45
1.5
1.3
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
72
501
1.48
2.44
1.7
1.7
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
18
83
2.19
2.42
1.1
1.2
—
—
—
0
0
(3019225) pH of Specimen
93
681
1.41
2.41
4.0
3.6
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
190
1551
1.29
2.39
4.8
3.7
kg/l
1.0
1.0
0.41
24
212
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
30
168
1.81
2.39
1.2
1.2
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
762
7284
1.34
2.32
4.9
4.1
mmol/l
4.7
4.7
0.70
723
6807
(3021879) Hepatitis B virus core Ab [Presence] in Serum
81
583
1.43
2.31
1.4
1.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
190
1560
1.28
2.28
1.6
1.4
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
71
501
1.45
2.26
2.1
2.8
g/l
66.7
67.3
0.29
64
455
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
323
2821
1.23
2.25
4.4
3.5
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
9
29
3.12
2.23
1.2
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
14
60
2.35
2.22
1.1
1.2
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
5
9
5.58
2.21
1.6
1.8
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
60
411
1.49
2.21
2.0
2.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
723
6873
1.29
2.21
20.2
13.3
%
39.7
39.9
0.22
555
5201
(3052851) Hemolysis interference index of Serum or Plasma
32
188
1.73
2.20
3.1
3.0
—
—
—
0
0
(3013512) EKG study
227
1914
1.25
2.18
4.1
3.5
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
6
167
0.35
2.16
1.7
1.5
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
14
61
2.32
2.15
1.1
1.2
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
6
14
4.31
2.15
1.8
1.9
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
38
237
1.63
2.11
2.2
2.1
ug/l
4.6
2.8
0.20
31
211
(3017446) Testosterone [Moles/volume] in Serum or Plasma
56
383
1.49
2.09
3.4
2.1
nmol/l
12.5
12.1
0.10
46
342
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
16
75
2.15
2.09
4.6
5.0
u/ml
10.4
57.8
—
6
24
(3049717) Cytology report of Urine Cyto stain
37
230
1.64
2.08
3.2
2.6
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
757
7253
1.31
2.08
4.8
4.1
mmol/l
1.5
1.5
1.96
711
6747
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
18
89
2.04
2.07
1.1
1.2
nmol/l
0.5
0.6
0.55
18
84
(3045683) HLA typing for celiac disease panel - Blood or Tissue
13
56
2.34
2.05
1.0
1.0
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
70
504
1.42
2.02
1.4
1.3
iu/l
25.5
28.7
0.39
59
436
(3020874) Milk IgE Ab [Units/volume] in Serum
11
44
2.52
2.01
1.1
1.1
u/ml
1.6
0.2
—
5
16
(3043410) Blood group antigens tested for on Red Blood Cells
8
26
3.10
2.01
1.3
1.2
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
8
26
3.10
2.01
1.3
1.2
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
9
32
2.83
2.00
1.0
1.2
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
35
217
1.64
2.00
2.5
2.0
g/l
2.8
3.1
1.78
27
171
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
35
217
1.64
2.00
1.5
1.3
—
—
—
0
0
(4062490)
15
70
2.16
1.99
1.4
1.2
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
39
250
1.59
1.96
2.6
5.6
%
1.7
1.6
0.30
39
235
(3037692) Legionella sp identified in Specimen by Organism specific culture
8
27
2.98
1.94
1.5
1.3
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
8
27
2.98
1.94
43.5
25.5
ug/l
7.0
7.2
—
8
22
(40760888) Immunoglobulin light chains.free panel - Serum
24
135
1.80
1.93
2.3
4.5
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
13
58
2.26
1.91
2.6
2.4
e9/l
1.5
1.1
—
6
32
(3003694) ABO and Rh group [Type] in Blood
247
2134
1.22
1.86
1.4
1.5
—
—
—
0
0
(3034426) Prothrombin time (PT)
8
28
2.87
1.86
1.8
1.3
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
40
262
1.55
1.84
7.2
3.7
mmol/l
24.4
24.1
0.27
35
235
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
9
35
2.59
1.80
1.4
2.4
u/ml
4305.0
653.4
—
9
35
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
36
232
1.58
1.78
2.5
2.0
g/l
6.9
7.5
1.53
27
177
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
36
232
1.58
1.78
2.5
2.0
g/l
3.9
3.8
0.10
27
167
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
36
232
1.58
1.78
2.5
2.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
6
18
3.35
1.75
1.0
1.1
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
37
242
1.55
1.73
1.5
1.6
iu/ml
0.1
0.0
—
10
44
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
18
96
1.89
1.71
1.0
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
11
48
2.31
1.71
1.3
1.2
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
54
384
1.43
1.70
1.7
2.1
u/l
5040.2
3892.8
0.13
17
159
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
113
903
1.29
1.69
3.0
2.9
ug/l
0.8
0.7
0.66
80
591
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
12
55
2.20
1.68
1.7
1.7
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
18
97
1.87
1.67
1.3
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
18
97
1.87
1.67
1.3
1.3
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
736
7071
1.25
1.66
4.8
4.2
mmol/l
5.9
5.8
1.12
691
6509
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
6
19
3.17
1.66
3.0
1.9
ug/l
59.2
56.9
—
6
19
(3024471) HLA-A [Type]
6
19
3.17
1.66
1.0
1.0
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
24
142
1.71
1.66
1.8
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
18
98
1.85
1.62
1.3
1.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
765
7388
1.27
1.61
5.4
4.5
mmol/l
2.7
2.8
1.73
721
6868
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
220
1906
1.21
1.60
1.7
1.6
mmol/l
1.6
1.4
2.27
199
1629
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
6
20
3.01
1.58
1.2
1.9
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
41
281
1.48
1.57
2.0
1.7
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
64
477
1.37
1.56
1.3
1.3
—
39.2
—
0
26
(3023420) DNA double strand Ab [Units/volume] in Serum
16
85
1.90
1.55
1.8
1.4
—
37.2
—
0
5
(3022313) Gas panel - Capillary blood
43
299
1.46
1.54
2.7
3.0
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
18
100
1.82
1.54
1.3
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
18
100
1.82
1.54
1.3
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
18
100
1.82
1.54
1.3
1.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
149
1249
1.23
1.50
4.1
4.2
%
21.5
21.7
0.06
85
574
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
51
693
0.72
1.49
3.2
3.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
104
839
1.27
1.47
1.5
1.4
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
15
80
1.89
1.45
1.2
1.1
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
5
16
3.14
1.44
1.6
1.4
—
—
—
0
0
(4133840)
5
16
3.14
1.44
1.0
1.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
35
237
1.50
1.44
3.8
3.2
g/l
0.2
0.3
0.31
19
90
(40760892) CBC W Ordered Manual Differential panel - Blood
199
1726
1.20
1.43
3.3
4.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
181
1558
1.20
1.41
5.2
4.8
ug/l
2.7
2.3
0.44
170
1388
(3039000) Anion gap in Blood
22
134
1.66
1.40
3.0
7.9
mmol/l
11.5
11.1
0.23
22
122
(3018572) Chloride [Moles/volume] in Blood
22
134
1.66
1.40
3.0
7.9
mmol/l
103.1
105.2
1.04
22
122
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32
214
1.51
1.40
2.7
2.0
g/l
10.0
10.4
0.30
27
185
(3045424) Erythrocytes [Presence] in Urine
20
119
1.70
1.38
2.2
1.5
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
21
127
1.67
1.37
1.6
1.4
u/ml
91.3
110.8
—
6
28
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
12
62
1.95
1.28
2.8
4.2
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
22
138
1.61
1.27
1.3
1.2
u/ml
180.5
270.7
1.57
11
85
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
30
203
1.49
1.26
1.4
1.2
u/ml
1.6
2.9
—
5
24
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
551
5213
1.15
1.25
3.7
3.3
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
47
349
1.37
1.22
1.5
1.5
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
40
289
1.40
1.21
2.8
3.3
mmol/l
25.3
25.3
0.02
40
283
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
104
861
1.24
1.20
4.5
4.1
%
31.2
32.2
0.38
69
592
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
36
256
1.42
1.19
1.4
2.0
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
6
26
2.32
1.19
1.8
1.5
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
8
38
2.12
1.18
3.5
2.7
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
30
207
1.47
1.16
1.4
1.2
u/ml
5.1
9.8
—
8
38
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
35
0.00
1.15
0.0
2.5
—
—
—
0
0
(1002224) Polysomnography panel
48
364
1.34
1.10
1.0
1.1
—
—
—
0
0
(3000492) Spirometry study
88
723
1.24
1.10
1.5
1.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
23
152
1.53
1.10
1.3
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
30
210
1.44
1.09
1.2
1.1
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
5
21
2.39
1.09
1.6
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
19
120
1.60
1.09
1.2
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
19
120
1.60
1.09
1.2
1.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
31
220
1.42
1.06
1.3
1.2
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
23
154
1.51
1.04
2.6
2.4
ug/min
68.0
112.8
0.38
15
94
(3004775) Volume in Urine collected for unspecified duration
9
46
1.97
1.03
2.3
2.2
ml
621.4
554.8
—
9
25
(3029937) Albumin [Presence] in Urine by Test strip
215
1930
1.15
1.01
4.8
3.7
estimate
0.0
0.0
1.08
63
685
(3028679) Herpes simplex virus Ab [Presence] in Serum
7
35
2.01
1.00
1.1
1.3
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
37
490
0.74
0.98
1.4
1.5
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
5
23
2.18
0.98
1.8
1.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
31
224
1.40
0.97
1.3
1.2
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
10
54
1.86
0.97
1.4
1.4
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
9
50
1.81
0.97
1.1
1.2
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
9
50
1.81
0.97
1.1
1.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
33
242
1.38
0.96
1.3
1.4
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
14
85
1.66
0.94
1.4
1.3
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
28
200
1.41
0.94
1.9
1.7
—
—
—
0
0
(3016750) Collection duration of Urine
7
37
1.90
0.94
2.1
2.2
min
498.6
497.7
—
7
23
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
52
410
1.29
0.94
3.0
3.0
kpa
5.1
5.1
0.07
44
386
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
22
150
1.48
0.93
1.5
1.6
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
6
27
2.23
0.93
1.3
1.7
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
6
27
2.23
0.93
1.3
1.7
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
6
27
2.23
0.93
1.3
1.7
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
12
70
1.72
0.93
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
12
70
1.72
0.93
1.1
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
12
70
1.72
0.93
1.1
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
30
218
1.39
0.92
1.3
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
124
1075
1.18
0.92
2.2
2.1
—
—
—
0
0
(44813793)
10
55
1.83
0.92
1.1
1.0
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
31
227
1.38
0.91
1.2
1.2
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
6
28
2.15
0.91
1.7
1.6
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
6
29
2.08
0.89
1.7
1.7
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
6
29
2.08
0.89
1.7
1.7
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
12
71
1.70
0.89
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
12
71
1.70
0.89
1.1
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
12
71
1.70
0.89
1.1
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
9
156
0.57
0.88
1.2
1.9
—
—
—
0
0
(4281824)
13
79
1.66
0.88
1.4
1.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
15
95
1.59
0.88
2.7
2.6
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
6
30
2.01
0.87
1.0
1.0
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
8
44
1.83
0.86
1.3
1.3
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
49
389
1.27
0.85
3.1
3.0
mmol/l
1.4
1.7
0.27
39
290
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
10
57
1.76
0.84
1.2
1.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
20
138
1.46
0.82
1.8
1.5
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
13
81
1.61
0.81
1.2
1.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
11
66
1.68
0.79
1.0
1.6
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
8
48
1.67
0.79
1.1
1.2
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
8
48
1.67
0.79
1.1
1.1
—
19.8
—
0
6
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
23
165
1.40
0.78
1.4
1.3
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
42
332
1.28
0.77
1.5
1.5
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
16
107
1.50
0.76
1.1
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
13
197
0.65
0.76
2.2
1.7
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
20
141
1.43
0.75
1.0
1.0
u/ml
1.3
2.1
—
9
68
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
110
964
1.16
0.74
2.0
2.0
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
9
55
1.64
0.73
1.6
1.3
mmol/l
6.2
6.3
—
9
50
(3000093) Morphology [Interpretation] in Blood Narrative
9
55
1.64
0.73
1.0
1.2
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
5
25
2.01
0.72
1.0
1.0
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
5
25
2.01
0.72
1.0
1.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
11
68
1.63
0.72
1.5
1.7
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
7
40
1.76
0.71
2.1
1.6
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
7
40
1.76
0.71
1.3
1.2
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
9
143
0.63
0.70
1.8
3.9
%
60.1
56.4
—
9
143
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
13
85
1.54
0.69
1.1
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
262
2809
0.90
0.69
2.6
2.7
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
38
302
1.27
0.69
1.4
1.4
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
10
61
1.65
0.68
1.1
1.5
nmol/l
1.8
1.6
—
10
54
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
5
27
1.86
0.68
1.0
2.7
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
7
42
1.67
0.68
1.0
1.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
160
1449
1.13
0.68
1.6
1.7
pmol/l
418.7
34258178.9
1.81
136
1226
(3027008) Opiates [Presence] in Urine
38
303
1.27
0.67
1.4
1.4
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
28
214
1.32
0.67
1.2
1.2
u/l
11.6
11.2
0.04
18
171
(3004616) Nuclear Ab [Presence] in Serum
13
86
1.52
0.66
1.8
1.3
—
—
—
0
0
(3035880) pH of Pleural fluid
5
28
1.79
0.66
1.4
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
38
305
1.26
0.64
1.4
1.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
14
95
1.48
0.64
1.4
1.6
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
23
301
0.76
0.62
1.5
1.9
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
9
138
0.65
0.61
1.8
3.5
e9/l
4.9
4.2
—
9
138
(3020876) Protein [Mass/time] in 24 hour Urine
8
51
1.57
0.60
1.5
2.1
—
0.9
—
0
5
(3036670) Protein [Mass/volume] in Synovial fluid
0
21
0.00
0.60
0.0
1.1
—
37.8
—
0
13
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
21
277
0.75
0.60
1.3
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
21
277
0.75
0.60
1.3
1.4
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
18
131
1.38
0.59
1.3
1.1
—
11.6
—
0
13
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
22
0.00
0.59
0.0
1.9
—
1.8
—
0
9
(3044927) Protein electrophoresis panel - Urine
11
72
1.53
0.59
1.4
1.1
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
21
276
0.76
0.59
1.3
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
21
276
0.76
0.59
1.3
1.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
221
2057
1.10
0.58
3.9
3.0
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
15
106
1.42
0.58
1.7
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
37
301
1.24
0.57
1.4
1.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
35
283
1.25
0.57
1.4
1.4
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
6
36
1.67
0.56
2.7
2.6
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
6
36
1.67
0.56
1.0
1.1
g/l
0.3
0.3
—
6
30
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
10
65
1.54
0.55
1.3
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
10
65
1.54
0.55
1.3
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
10
65
1.54
0.55
1.3
1.6
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
16
116
1.39
0.54
1.4
1.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
6
38
1.58
0.54
1.3
1.6
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
6
38
1.58
0.54
1.3
1.6
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
6
38
1.58
0.54
1.3
1.6
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
6
38
1.58
0.54
1.3
1.6
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
17
125
1.37
0.54
1.3
1.6
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
9
61
1.48
0.54
2.1
1.5
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
11
74
1.49
0.53
4.7
2.0
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
9
62
1.46
0.53
2.3
2.6
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
9
62
1.46
0.53
1.0
1.0
mg/l
180.2
230.2
—
9
51
(3008757) Leukocyte morphology finding [Identifier] in Blood
10
66
1.52
0.52
2.9
3.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
36
296
1.23
0.52
1.4
1.2
—
—
—
0
0
(44790049)
12
83
1.45
0.52
1.6
1.6
—
—
—
0
0
(44806118)
12
83
1.45
0.52
1.6
1.6
—
—
—
0
0
(44790048)
12
83
1.45
0.52
1.6
1.6
—
—
—
0
0
(44790047)
12
83
1.45
0.52
1.6
1.6
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
17
126
1.36
0.52
1.2
1.1
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
9
65
1.39
0.50
1.2
1.1
mg/l
33.4
34.0
—
9
51
(3028707) Methadone [Presence] in Urine by Screen method
17
127
1.35
0.50
1.6
1.6
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
21
163
1.30
0.48
1.5
1.7
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
26
208
1.26
0.48
1.2
1.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
38
318
1.20
0.48
1.1
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
39
462
0.84
0.48
2.2
2.5
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
14
102
1.38
0.47
1.2
1.2
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
12
85
1.42
0.47
1.2
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
15
113
1.33
0.43
1.5
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
13
96
1.36
0.41
1.6
1.5
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
18
228
0.79
0.41
1.5
1.5
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
8
58
1.38
0.41
1.0
1.0
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
5
33
1.52
0.41
1.6
2.1
%
182.1
122.5
—
5
33
(21494755) Public health laboratory ask at order entry panel
78
865
0.89
0.41
1.4
1.3
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
39
333
1.18
0.41
1.4
1.7
mg/l
3.9
3.3
0.19
29
229
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
0
16
0.00
0.41
0.0
2.3
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
16
0.00
0.41
0.0
1.3
—
2.2
—
0
16
(3006653) Thiamine [Moles/volume] in Blood
5
34
1.47
0.40
2.0
1.4
nmol/l
140.6
149.6
—
5
34
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
5
35
1.43
0.39
1.2
1.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
5
35
1.43
0.39
1.2
1.2
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
18
225
0.80
0.38
1.3
1.4
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
5
36
1.39
0.38
1.0
1.1
%
100.8
113.6
—
5
29
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
5
36
1.39
0.38
1.0
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
67
601
1.12
0.38
1.2
1.2
iu/ml
148.2
154.8
0.04
24
247
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
21
170
1.24
0.37
1.4
1.7
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
8
111
0.72
0.37
3.8
2.3
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
8
111
0.72
0.37
1.0
1.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
18
224
0.80
0.37
1.3
1.4
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
5
77
0.65
0.36
1.0
1.1
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
20
162
1.24
0.35
1.4
1.4
u/l
23.9
27.4
0.19
15
135
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
25
298
0.83
0.35
1.4
1.5
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
6
43
1.40
0.35
2.5
1.3
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
19
232
0.81
0.34
1.4
1.5
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
6
45
1.34
0.34
2.7
1.7
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
15
118
1.28
0.33
2.0
1.6
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
29
339
0.85
0.33
1.6
1.4
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
60
540
1.12
0.33
3.9
4.3
%
0.1
0.1
0.18
12
154
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
61
550
1.12
0.33
5.0
3.4
mmol/l
1.2
1.2
0.29
55
477
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
10
74
1.36
0.32
1.2
1.1
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
170
1609
1.07
0.32
1.9
1.8
—
—
—
0
0
(1616796) Gas panel - Central venous blood
10
132
0.75
0.32
4.0
2.5
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
12
92
1.31
0.32
1.6
1.7
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
14
110
1.28
0.32
1.1
1.1
—
72.8
—
0
25
(3051611) Lipemic interference index of Serum or Plasma
7
55
1.27
0.30
3.4
2.6
—
—
—
0
0
(4027681)
7
56
1.25
0.29
1.0
1.1
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
7
57
1.23
0.29
1.3
1.3
—
62.3
—
0
8
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
18
149
1.21
0.28
1.1
1.4
nmol/l
0.3
0.3
0.56
13
118
(3045142) Bone marrow Pathology biopsy report
8
67
1.20
0.26
1.9
1.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
15
123
1.22
0.25
1.2
1.6
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
9
73
1.24
0.25
1.0
1.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
25
217
1.16
0.24
1.5
1.9
iu/l
1.8
4.9
—
6
82
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
31
274
1.14
0.24
1.7
1.8
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
28
246
1.14
0.24
1.6
1.7
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
5
38
1.32
0.23
1.2
1.2
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
5
38
1.32
0.23
1.0
1.7
—
69.4
—
0
5
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
12
97
1.24
0.23
1.2
1.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
21
181
1.16
0.22
1.4
1.5
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
5
40
1.25
0.22
1.4
1.4
mmol/l
5.1
6.2
—
5
40
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
41
1.22
0.22
1.0
1.1
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
5
42
1.19
0.21
1.2
2.0
mmol/l
7.4
9.1
—
5
36
(4034850)
21
241
0.87
0.21
4.7
8.7
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
10
0.00
0.21
0.0
2.9
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
10
0.00
0.21
0.0
3.0
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
10
0.00
0.21
0.0
2.7
—
0.5
—
0
10
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
10
0.00
0.21
0.0
7.0
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
12
98
1.23
0.21
1.6
1.6
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
13
0.00
0.21
0.0
6.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
10
80
1.25
0.20
1.1
1.7
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
14
0.00
0.20
0.0
6.4
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
6
50
1.20
0.19
1.7
1.1
—
1.0
—
0
18
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
96
911
1.06
0.19
1.9
1.8
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
6
53
1.13
0.18
1.3
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
12
143
0.84
0.18
1.8
1.7
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
49
528
0.92
0.18
1.4
1.4
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
7
58
1.21
0.18
1.6
1.7
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
7
59
1.19
0.18
1.4
1.1
—
79.0
—
0
6
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
8
69
1.16
0.16
3.5
2.7
u/ml
21.0
59.5
—
8
69
(3019832) Treponema pallidum Ab [Presence] in Serum
87
913
0.95
0.16
1.6
1.6
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
37
341
1.09
0.16
1.3
1.5
mu/l
275.7
308.7
0.39
32
308
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
17
149
1.14
0.15
1.6
1.6
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
14
122
1.15
0.13
1.8
1.8
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
14
122
1.15
0.13
1.1
1.4
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
55
525
1.05
0.10
3.6
4.2
%
0.0
0.6
—
9
129
(3024928) Oxygen saturation in Venous blood
14
125
1.12
0.10
4.0
2.7
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
60
575
1.05
0.10
3.9
4.2
%
1.1
1.0
0.04
12
172
(3011648) Oxygen content in Venous blood
5
44
1.14
0.10
1.4
1.9
%
11.0
10.9
—
5
44
(3025159) Blasts/100 leukocytes in Blood
54
517
1.05
0.09
3.8
4.4
%
0.0
0.8
—
10
132
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
5
48
1.04
0.09
1.8
1.7
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
17
155
1.10
0.09
1.0
1.6
—
—
—
0
0
(21494434) Karyotype in Bone marrow
6
55
1.09
0.09
1.0
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
18
165
1.09
0.08
5.5
4.4
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
6
56
1.07
0.08
1.2
1.1
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
6
57
1.05
0.08
1.0
1.4
promille
1.2
1.2
—
6
45
(3012441) Differential panel - Pleural fluid
6
57
1.05
0.08
2.5
1.3
—
—
—
0
0
(4146454)
7
65
1.08
0.08
4.3
2.8
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
72
743
0.97
0.08
1.5
1.6
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
6
70
0.86
0.07
1.2
1.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
7
81
0.86
0.07
3.1
2.5
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
7
82
0.85
0.07
3.1
2.5
mmol/l
4.5
4.0
—
7
82
(3035285) Chloride [Moles/volume] in Venous blood
7
82
0.85
0.07
3.1
2.5
mmol/l
107.9
106.0
—
7
82
(3042631) Mycobacterium sp identified in Specimen
9
84
1.07
0.07
2.7
2.6
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
18
167
1.08
0.07
1.6
1.6
e6/l
6111.9
14921.7
—
10
125
(3047007) Chlamydophila sp Ab [Presence] in Serum
14
128
1.10
0.06
1.6
1.2
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
12
109
1.10
0.06
1.2
1.5
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
32
306
1.05
0.05
1.1
1.3
miu/ml
221.1
247.9
0.24
16
148
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
20
188
1.07
0.05
1.2
1.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
46
445
1.04
0.05
1.4
1.4
—
—
—
0
0
(4094501)
17
178
0.95
0.02
1.2
1.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
14
133
1.05
0.01
1.5
1.7
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
15
157
0.95
0.01
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
14
146
0.96
0.00
1.1
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
14
146
0.96
0.00
1.1
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
53
524
1.01
0.00
1.8
1.8
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
32
316
1.01
0.00
1.8
1.7
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
14
138
1.01
0.00
2.5
2.0
g/l
129.9
129.8
—
7
102
(3000330) Specific gravity of Urine by Test strip
33
329
1.00
0.00
4.2
3.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
20
203
0.98
0.00
1.4
1.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
10
95
1.05
0.00
1.1
1.6
—
—
—
0
0
(4024509)
5
58
0.86
0.00
2.0
1.3
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
7
73
0.96
0.00
1.6
1.8
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
9.6
—
0
6
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
5
0.00
0.00
0.0
1.4
—
2.7
—
0
5
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
7
69
1.01
0.00
1.0
2.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
11
110
1.00
0.00
1.1
1.5
—
—
—
0
0
(40758358) Immune stain study
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
5
51
0.98
0.00
1.0
1.4
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
41.0
—
0
7
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
8
83
0.96
0.00
2.0
2.3
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
6.0
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
8
0.00
0.00
0.0
1.0
—
18.3
—
0
8
(3001729) Color of Synovial fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
7
76
0.92
0.00
1.9
2.0
pg
32.4
32.3
—
7
76
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
8
89
0.90
0.00
1.1
1.1
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_LIVE_BILE and mortality.

Females

Parameter HR [95% CI] p-value
CD2_BENIGN_LIVE_BILE 1.65 [1.41, 1.93] < 0.001
Birth year 0.994 [0.99, 1.0] 0.164

During the follow-up period (1.1.1998 — 31.12.2019), 315 out of 2402 females with CD2_BENIGN_LIVE_BILE died.

Males

Parameter HR [95% CI] p-value
CD2_BENIGN_LIVE_BILE 1.985 [1.62, 2.42] < 0.001
Birth year 0.986 [0.98, 1.0] 0.004

During the follow-up period (1.1.1998 — 31.12.2019), 310 out of 1102 males with CD2_BENIGN_LIVE_BILE died.

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_LIVE_BILE.

N-year risk Females Males
1 0.15% 0.324%
5 0.89% 2.124%
10 2.35% 5.521%
15 4.438% 10.241%
20 7.635% 16.824%

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_LIVE_BILE – Benign neoplasm: Liver/bile ducts

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data